Nitric oxide inhibits gastric cancer cell growth through the modulation of the Akt pathway

Molecular Medicine Reports

Volumn 4, Issue 6, 2011, Pages 1163-1167

  Sang, Jianrong ^a   Chen, Yongchang ^a   Tao, Yan ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Akt; Cell growth; Gastric cancer cells; Nitric oxide

Indexed keywords

CYCLIN D1; CYCLIN E; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROTEIN KINASE B; PROTEIN P21;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH CANCER;

CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; NITRIC OXIDE DONORS; NITROPRUSSIDE; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 80053116756     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.535     Document Type: Article

References (27)

1. Gow AJ and Ischiropoulos H: Nitric oxide chemistry and cellular signaling. J Cell Physiol 187: 277-282, 2001. (Pubitemid 32378352)
2. Davis KL, Martin E, Turko IV and Murad F: Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41: 203-236, 2001. (Pubitemid 32385888)
3. Contestabile A, Monti B and Ciani E: Brain nitric oxide and its dual role in neurodegeneration/neuroprotection: understanding molecular mechanisms to devise drug approaches. Curr Med Chem 10: 2147-2174, 2003. (Pubitemid 37139068)
4. Villalobo A: Nitric oxide and cell proliferation. FEBS J 273: 2329-2344, 2006.
5. Villalobo A: Enhanced cell proliferation induced by nitric oxide. Dyn Cell Biol 1: 60-64, 2007.
6. Wang Y, Ding H and Xiao GF: esearch advances on tumor therapy via nitric oxide. Chin J Cancer 23: 476-479, 2004.
7. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
8. Sherr CJ: G1 phase progression: cycling on cue. Cell 79: 551-555, 1994.
9. Jin ZH, Kurosu T, Yamaguchi M, Arai A and Miura O: Hemato- poietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene 24: 1973-1981, 2005. (Pubitemid 40516192)
10. Siebert R, Willers CP and Opalka B: Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma. Leuk Lymphoma 23: 505-520, 1996. (Pubitemid 27029661)
11. Sherr CJ and Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995.
12. Zhang H, Hannon GJ and Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750-1758, 1994.
13. Clark JA, Black AR, Leontieva OV, Frey MR, Pysz MA, Kunneva L, Woloszynska-Read A, Roy D and Black JD: Involvement of the ERK signaling cascade in protein kinase C-mediated cell cycle arrest in intestinal epithelial cells. J Biol Chem 279: 9233-9247, 2004. (Pubitemid 38295987)
14. Zuckerbraun BS, Stoyanovsky DA, Sengupta R, Shapiro RA, Ozanich BA, Rao J, Barbato JE and Tzeng E: Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA. Am J Physiol Cell Physiol 292: 824-831, 2007.
15. Wang XJ, SunHY and Li CL: Nitric oxide induces promyelocytic cell growth arrest and apoptosis through deactivation of Akt pathway. Leuk Res 31: 653-660, 2007.
16. Oh-hashi K, Maruyama W, Yi H, Takahashi T, Naoi M and Isobe K: Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun 263: 504-509, 1999. (Pubitemid 29467225)
17. Iwata N, Tamekane A,Yakushijin K, Nishikawa S, Hamaguchi M, Fukui C, Yamamoto K and Matsui T: Casein kinase Iepsilon downregulates phospho-Akt via PTEN, following genotoxic stress-induced apoptosis in hematopoietic cells. Life Sci 78: 1624-1629, 2006. (Pubitemid 43259472)
18. Hammerman PS, Fox CJ, Birnbaum MJ and Thompson CB: Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105: 4477-4483, 2005. (Pubitemid 40720797)
19. Jin ZH, Kurosu T, Yamaguchi M, Arai A and Miura O: Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene 24: 1973-1981, 2005. (Pubitemid 40516192)
20. Bertrand FE, Steelman LS, Chappell WH, Abrams SL, Shelton JG, White ER, Ludwig DL and McCubrey JA: Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells. Leukemia 20: 1254-1260, 2006. (Pubitemid 43905829)
21. Eldrige SR, Butterworth BE and Goldsworthy TL: Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents. Environ Health Perspect 101 (Suppl 5): 211-218, 1993. (Pubitemid 24096352)
22. Santamaria D and Ortega S: Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci 11: 1164-1188, 2006. (Pubitemid 43253468)
23. Horne MM and Guadagno TM: A requirement for MAP kinase in the assembly and maintenance of the mitotic spindle. J Cell Biol 161: 1021-1028, 2003. (Pubitemid 36870164)
24. Friday BB and Adjei AA: Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin Cancer Res 14: 342-346, 2008. (Pubitemid 351226098)
25. Roberts PJ and Der CJ: Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310, 2007. (Pubitemid 46763022)
26. Hardingham GE, Arnold FJ and Bading H: A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat Neurosci 4: 565-566, 2001. (Pubitemid 32507368)
27. Lee J, Hong F, Dwon S, Kim SS, Kim OD, Kang HS, Lee SJ, Ha J and Kim SS: Activation of p38, MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation. Biochem Biophys Res Commun 298: 765-771, 2002. (Pubitemid 35356806)